We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Adma Biologics Inc | NASDAQ:ADMA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.17 | -2.55% | 6.50 | 6.67 | 6.85 | 338 | 09:01:26 |
ADMA BIOLOGICS, INC.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-36728 |
56-2590442
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
465 State Route 17, Ramsey, New Jersey
|
07446
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(Former name or former address, if changed since last report.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
ADMA
|
Nasdaq Global Market
|
Exhibit No.
|
Description
|
Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named
therein, dated as of December 7, 2022
|
|
Press Release of the Company, dated December 7, 2022
|
|
104 |
Cover Page Interactive Data File (embedded with the Inline XBRL document) |
December 7, 2022
|
ADMA Biologics, Inc.
|
||
By:
|
/s/ Brian Lenz
|
||
Name:
|
Brian Lenz
|
||
Title:
|
Executive Vice President and Chief Financial Officer
|
1 Year Adma Biologics Chart |
1 Month Adma Biologics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions